{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:45:05Z","timestamp":1786981505901,"version":"build-2736575974"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2014,2,14]],"date-time":"2014-02-14T00:00:00Z","timestamp":1392336000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharm Res"],"published-print":{"date-parts":[[2014,7]]},"DOI":"10.1007\/s11095-013-1272-4","type":"journal-article","created":{"date-parts":[[2014,2,13]],"date-time":"2014-02-13T12:34:10Z","timestamp":1392294850000},"page":"1676-1688","source":"Crossref","is-referenced-by-count":25,"title":["Commonly Used Excipients Modulate UDP-Glucuronosyltransferase 2B7 Activity to Improve Nalbuphine Oral Bioavailability in Humans"],"prefix":"10.1007","volume":"31","author":[{"given":"Hong-Jaan","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng-Huei","family":"Hsiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shung-Tai","family":"Ho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min-Jen","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tung-Yuan","family":"Shih","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pei-Wei","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver Yoa-Pu","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,2,14]]},"reference":[{"key":"1272_CR1","doi-asserted-by":"crossref","first-page":"2535","DOI":"10.2174\/092986706778201648","volume":"13","author":"H Kalasz","year":"2006","unstructured":"Kalasz H, Antal I. Drug excipients. Curr Med Chem. 2006;13:2535\u201363.","journal-title":"Curr Med Chem"},{"issue":"6","key":"1272_CR2","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/j.addr.2007.09.010","volume":"60","author":"ML Chen","year":"2008","unstructured":"Chen ML. Lipid excipients and delivery systems for pharmaceutical development: a regulatory perspective. Adv Drug Deliv Rev. 2008;60(6):768\u201377.","journal-title":"Adv Drug Deliv Rev"},{"issue":"15","key":"1272_CR3","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1016\/j.addr.2007.08.017","volume":"59","author":"TR Buggins","year":"2007","unstructured":"Buggins TR, Dickinson PA, Taylor G. The effects of pharmaceutical excipients on drug disposition. Adv Drug Deliv Rev. 2007;59(15):1482\u2013503.","journal-title":"Adv Drug Deliv Rev"},{"issue":"5","key":"1272_CR4","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/S0009-9236(03)00010-9","volume":"73","author":"C Wandel","year":"2003","unstructured":"Wandel C, Kim RB, Stein CM. \u201cInactive\u201d excipients such as Cremophor can affect in vivo drug disposition. Clin Pharmacol Ther. 2003;73(5):394\u20136.","journal-title":"Clin Pharmacol Ther"},{"issue":"1","key":"1272_CR5","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1002\/bdd.383","volume":"25","author":"RC Bravo Gonz\u00e1lez","year":"2004","unstructured":"Bravo Gonz\u00e1lez RC, Huwyler J, Boess F, Walter I, Bittner B. In vitro investigation on the impact of the surface-active excipients Cremophor EL, Tween 80 and Solutol HS 15 on the metabolism of midazolam. Biopharm Drug Dispos. 2004;25(1):37\u201349.","journal-title":"Biopharm Drug Dispos"},{"issue":"5","key":"1272_CR6","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/S0009-9236(03)00059-6","volume":"73","author":"Y Tayrouz","year":"2003","unstructured":"Tayrouz Y, Ding R, Burhenne J, Riedel KD, Weiss J, Hoppe-Tichy T, et al. Pharmacokinetic and pharmaceutic interaction between digoxin and Cremophor RH40. Clin Pharmacol Ther. 2003;73(5):397\u2013405.","journal-title":"Clin Pharmacol Ther"},{"issue":"4","key":"1272_CR7","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1002\/bdd.353","volume":"24","author":"B Bittner","year":"2003","unstructured":"Bittner B, Gonz\u00e1lez RC, Walter I, Kapps M, Huwyler J. Impact of Solutol HS 15 on the pharmacokinetic behaviour of colchicine upon intravenous administration to male Wistar rats. Biopharm Drug Dispos. 2003;24(4):173\u201381.","journal-title":"Biopharm Drug Dispos"},{"issue":"1\u20132","key":"1272_CR8","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0378-5173(00)00586-X","volume":"211","author":"RJ Mountfield","year":"2000","unstructured":"Mountfield RJ, Senepin S, Schleimer M, Walter I, Bittner B. Potential inhibitory effects of formulation ingredients on intestinal cytochrome P450. Int J Pharm. 2000;211(1\u20132):89\u201392.","journal-title":"Int J Pharm"},{"key":"1272_CR9","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.ijpharm.2004.03.001","volume":"278","author":"G Cornaire","year":"2004","unstructured":"Cornaire G, Woodley J, Hermann P, Cloarec A, Arellano C, Houin G. Impact of excipients on the absorption of P-glycoprotein substrates in vitro and in vivo. Int J Pharm. 2004;278:119\u201331.","journal-title":"Int J Pharm"},{"key":"1272_CR10","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.ejps.2008.11.002","volume":"36","author":"X Ren","year":"2009","unstructured":"Ren X, Mao X, Cao L, Xue K, Si L, Qiu J, et al. Nonionic surfactants are strong inhibitors of cytochrome p4503A biotransformation activity in vitro and in vivo. Eur J Pharm Sci. 2009;36:401\u201311.","journal-title":"Eur J Pharm Sci"},{"key":"1272_CR11","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1038\/nrd3226","volume":"9","author":"I Melnikova","year":"2010","unstructured":"Melnikova I. Pain market. Nat Rev Drug Discov. 2010;9:589\u201390.","journal-title":"Nat Rev Drug Discov"},{"key":"1272_CR12","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1136\/pgmj.2010.112045","volume":"88","author":"S Snidvongs","year":"2012","unstructured":"Snidvongs S, Mehta V. Recent advances in opioid prescription for chronic non-cancer pain. Postgrad Med J. 2012;88:66\u201372.","journal-title":"Postgrad Med J"},{"key":"1272_CR13","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1345\/aph.1G259","volume":"40","author":"CM Amabile","year":"2006","unstructured":"Amabile CM, Bowman BJ. Overview of oral modified-release opioid products for the management of chronic pain. Ann Pharmacother. 2006;40:1327\u201335.","journal-title":"Ann Pharmacother"},{"issue":"2","key":"1272_CR14","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1038\/clpt.1981.28","volume":"29","author":"WT Beaver","year":"1981","unstructured":"Beaver WT, Feise GA, Robb D. Analgesic effect of intramuscular and oral nalbuphine in postoperative pain. Clin Pharmacol Ther. 1981;29(2):174\u201380.","journal-title":"Clin Pharmacol Ther"},{"issue":"3","key":"1272_CR15","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1111\/j.1526-4610.2012.02097.x","volume":"52","author":"NE Kelley","year":"2012","unstructured":"Kelley NE, Tepper DE. Rescue therapy for acute migraine, part 3: opioids, NSAIDs, steroids, and post-discharge medications. Headache. 2012;52(3):467\u201382.","journal-title":"Headache"},{"issue":"11","key":"1272_CR16","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1093\/bja\/59.11.1356","volume":"59","author":"CC Pugh","year":"1987","unstructured":"Pugh CC, Drummond RA. A dose-response study with nalbuphine hydrochloride for pain in patients after upper abdominal surgery. Br J Anaesth. 1987;59(11):1356\u201364.","journal-title":"Br J Anaesth"},{"key":"1272_CR17","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1007\/BF02968252","volume":"29","author":"S Jang","year":"2006","unstructured":"Jang S, Kim H, Kim D, Jeong MW, Ma T, Kim S, et al. Attenuation of morphine tolerance and withdrawal syndrome by coadministration of nalbuphine. Arch Pharm Res. 2006;29:677\u201384.","journal-title":"Arch Pharm Res"},{"issue":"3\u20134","key":"1272_CR18","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/0376-8716(85)90066-3","volume":"14","author":"WK Schmidt","year":"1985","unstructured":"Schmidt WK, Tam SW, Shotzberger GS, Smith Jr DH, Clark R, Vernier VG. Nalbuphine. Drug Alcohol Depen. 1985;14(3\u20134):339\u201362.","journal-title":"Drug Alcohol Depen"},{"issue":"2","key":"1272_CR19","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1111\/j.1365-2125.1988.tb03300.x","volume":"25","author":"AR Aitkenhead","year":"1988","unstructured":"Aitkenhead AR, Lin ES, Achola KJ. The pharmacokinetics of oral and intravenous nalbuphine in healthy volunteers. Br J Clin Pharmacol. 1988;25(2):264\u20138.","journal-title":"Br J Clin Pharmacol"},{"issue":"11","key":"1272_CR20","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1002\/j.1552-4604.1987.tb05581.x","volume":"27","author":"MW Lo","year":"1987","unstructured":"Lo MW, Schary WL, Whitney Jr CC. The disposition and bioavailability of intravenous and oral nalbuphine in healthy volunteers. J Clin Pharmacol. 1987;27(11):866\u201373.","journal-title":"J Clin Pharmacol"},{"key":"1272_CR21","author":"HJ Wang","year":"2013","unstructured":"Wang HJ, Hsiong CH, Pao LH, Chang WL, Zhang LJ, Lin MJ, et al. New finding of nalbuphine metabolites in men: NMR spectroscopy and UPLC\u2013MS\/MS spectrometry assays in a pilot human study. Metabolomics. 2013. doi: 10.1007\/s11306-013-0605-y .","journal-title":"Metabolomics"},{"issue":"2","key":"1272_CR22","doi-asserted-by":"crossref","first-page":"143","DOI":"10.2174\/1389200003339171","volume":"1","author":"CD King","year":"2000","unstructured":"King CD, Rios GR, Green MD, Tephly TR. UDP-glucuronosyltransferases. Curr Drug Metab. 2000;1(2):143\u201361.","journal-title":"Curr Drug Metab"},{"issue":"3","key":"1272_CR23","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1093\/bja\/61.3.313","volume":"61","author":"B Kay","year":"1988","unstructured":"Kay B, Lindsay RG, Mason CJ, Healy TE. Oral nalbuphine for the treatment of pain after dental extractions. Br J Anaesth. 1988;61(3):313\u20137.","journal-title":"Br J Anaesth"},{"issue":"4","key":"1272_CR24","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1038\/clpt.1982.196","volume":"32","author":"R Okun","year":"1982","unstructured":"Okun R. Analgesic effects of oral nalbuphine and codeine in patients with postoperative pain. Clin Pharmacol Ther. 1982;32(4):517\u201324.","journal-title":"Clin Pharmacol Ther"},{"key":"1272_CR25","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/0376-8716(87)90007-X","volume":"20","author":"GW Hanks","year":"1987","unstructured":"Hanks GW. The clinical usefulness of agonist-antagonistic opioid analgesics in chronic pain. Drug Alcohol Depend. 1987;20:339\u201346.","journal-title":"Drug Alcohol Depend"},{"issue":"1","key":"1272_CR26","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1142\/S0192415X1250005X","volume":"40","author":"LH Pao","year":"2012","unstructured":"Pao LH, Hu OYP, Fan HY, Lin CC, Liu LC, Huang PW. Herb-drug interaction of 50 Chinese herbal medicines on CYP3A4 activity in vitro and in vivo. Am J Chin Med. 2012;40(1):57\u201373.","journal-title":"Am J Chin Med"},{"key":"1272_CR27","first-page":"1","volume":"25","author":"BL Coffman","year":"1997","unstructured":"Coffman BL, Rios GR, King CD, Tephly TR. Human UGT2B7 catalyzes morphine glucuronidation. Drug Metab Dispos. 1997;25:1\u20134.","journal-title":"Drug Metab Dispos"},{"issue":"1","key":"1272_CR28","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1111\/j.1600-0773.1994.tb00319.x","volume":"75","author":"A Wahlstrom","year":"1994","unstructured":"Wahlstrom A, Lenhammar L, Ask B, Rane A. Tricyclic antidepressants inhibit opioid receptor binding in human brain and hepatic morphine glucuronidation. Pharmacol Toxicol. 1994;75(1):23\u20137.","journal-title":"Pharmacol Toxicol"},{"key":"1272_CR29","first-page":"102","volume":"80","author":"JJ Wang","year":"1995","unstructured":"Wang JJ, Ho ST, Hu OYP, Chu KM. An innovative cold tail-flick test: the cold ethanol tail-flick test. Anesth Analg. 1995;80:102\u20137.","journal-title":"Anesth Analg"},{"key":"1272_CR30","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1159\/000200957","volume":"52","author":"HS Tang","year":"1992","unstructured":"Tang HS, Hu OYP. Assessment of liver function using a novel galactose single point method. Digestion. 1992;52:222\u201331.","journal-title":"Digestion"},{"key":"1272_CR31","doi-asserted-by":"crossref","first-page":"2639","DOI":"10.1007\/s11095-012-0767-8","volume":"29","author":"R Panakanti","year":"2012","unstructured":"Panakanti R, Narang AS. Impact of excipient interactions on drug bioavailability from solid dosage forms. Pharm Res. 2012;29:2639\u201359.","journal-title":"Pharm Res"},{"key":"1272_CR32","unstructured":"World Health Organization. http:\/\/www.inchem.org\/documents\/jecfa\/jecmono\/v05je47.htm"},{"key":"1272_CR33","unstructured":"World Health Organization. http:\/\/www.inchem.org\/documents\/jecfa\/jecmono\/v05je19.htm"},{"key":"1272_CR34","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1146\/annurev.pharmtox.40.1.581","volume":"40","author":"RH Tukey","year":"2000","unstructured":"Tukey RH, Strassburg CP. Human UDP-glucuronosyltransferases: metabolism, expression, and disease. Annu Rev Pharmacol Toxicol. 2000;40:581\u2013616.","journal-title":"Annu Rev Pharmacol Toxicol"},{"issue":"4\u20135","key":"1272_CR35","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S0928-0987(02)00055-6","volume":"16","author":"BD Rege","year":"2002","unstructured":"Rege BD, Kao JPY, Polli JE. Effects of nonionic surfactants on membrane transporters in Caco-2 cell monolayers. Eur J Pharm Sci. 2002;16(4\u20135):237\u201346.","journal-title":"Eur J Pharm Sci"},{"issue":"6","key":"1272_CR36","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/j.tiv.2004.04.006","volume":"18","author":"MEF Silva da","year":"2004","unstructured":"da Silva MEF, Meirelles NC. Interaction of non-ionic surfactants with hepatic CYP in Prochilodus scrofa. Toxicol in Vitro. 2004;18(6):859\u201367.","journal-title":"Toxicol in Vitro"},{"key":"1272_CR37","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1002\/jps.2600750226","volume":"75","author":"MA Hussain","year":"1986","unstructured":"Hussain MA, Aungst BJ, Shefter E. Buccal and oral bioavailability of nalbuphine in rats. J Pharm Sci. 1986;75:218\u20139.","journal-title":"J Pharm Sci"},{"issue":"10","key":"1272_CR38","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1054\/bjoc.2001.2118","volume":"85","author":"MM Malingre","year":"2001","unstructured":"Malingre MM, Schellens JH, Van Tellingen O, Ouwehand M, Bardelmeijer HA, Rosing H, et al. The co-solvent Cremophor EL limits absorption of orally administered paclitaxel in cancer patients. Br J Cancer. 2001;85(10):1472\u20137.","journal-title":"Br J Cancer"},{"key":"1272_CR39","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.ejps.2009.05.001","volume":"37","author":"S Zhu","year":"2009","unstructured":"Zhu S, Huang R, Hong M, Jiang Y, Hu Z, Liu C, et al. Effects of polyoxyethylene (40) stearate on the activity of P-glycoprotein and cytochrome P450. Eur J Pharm Sci. 2009;37:573\u201380.","journal-title":"Eur J Pharm Sci"}],"container-title":["Pharmaceutical Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11095-013-1272-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11095-013-1272-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11095-013-1272-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T01:54:42Z","timestamp":1559354082000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11095-013-1272-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,2,14]]},"references-count":39,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2014,7]]}},"alternative-id":["1272"],"URL":"https:\/\/doi.org\/10.1007\/s11095-013-1272-4","relation":{},"ISSN":["0724-8741","1573-904X"],"issn-type":[{"value":"0724-8741","type":"print"},{"value":"1573-904X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,2,14]]}}}